This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wood, M. J. Search for Related Content Social Bookmarking                         What's this?

Over the counter statins — a good idea?

Diagnostic and Clinical Support Services Fairfield General Hospital, Rochdale Old Road, Bury, Lancashire, BL9 7TD, UK, Jayne.Wood{at}pat.nhs.uk

References

• Haffner SM, Lehto S., Ronnemaa T. et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. New Engl J Med 1998;339:229-34.[Abstract/Free Full Text]
• Long-term intervention with pravastatin in ischaemic disease (LIPID) study group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. New Engl J Med 1998;339:1349-57.[Abstract/Free Full Text]
• Sacks FM, Pfeffer MA, Moye LA et al. For the cholesterol and recurrent events trial investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New Engl J Med 1996;335:1001-09.[Abstract/Free Full Text]
• Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 444 patients with coronary heart disease: the Scandinavian Survival Study (4S). Lancet 1994;344:1383-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Shepherd J., Ford I., Cobbe SM et al. for the West of Scotland Coronary Prevention Study Group (WOSCOP). Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. New Engl J Med 1995;333:1301-07.[Abstract/Free Full Text]
• Downs JR, Clearfield M., Weis S. et al. for the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998;279:1615-22.[Abstract/Free Full Text]
• Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Jones P., Kafonek S., Laurora I. et al. Comparative dose efficacy of atorvastatin versus simvastatin, pravastatin, lovastatin and fluvastatin in patients with hypercholesterolaemia (the CURVES study). Am J Cardiol 1998;81: 582-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Royal Pharmaceutical Society. Practice Guidance: OTC Simvastatin 10 mg. Pharm J 2004;273:169-70.
• Ellis JJ, Erickson SR, Stevenson JG et al. Sub-optimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med 2004;19:638-45.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 2, 51-53 (2005)
DOI: 10.1177/14746514050050020101


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wood, M. J. Search for Related Content Social Bookmarking                         What's this?